Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Return on Assets (2016 - 2025)

Historic Return on Assets for Anika Therapeutics (ANIK) over the last 15 years, with Q3 2025 value amounting to 0.1%.

  • Anika Therapeutics' Return on Assets fell 500.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.2% for FY2024, which is 500.0% up from last year.
  • As of Q3 2025, Anika Therapeutics' Return on Assets stood at 0.1%, which was down 500.0% from 0.25% recorded in Q2 2025.
  • In the past 5 years, Anika Therapeutics' Return on Assets registered a high of 0.04% during Q2 2024, and its lowest value of 0.25% during Q2 2025.
  • In the last 5 years, Anika Therapeutics' Return on Assets had a median value of 0.02% in 2022 and averaged 0.06%.
  • Per our database at Business Quant, Anika Therapeutics' Return on Assets skyrocketed by 800bps in 2021 and then plummeted by -2900bps in 2025.
  • Anika Therapeutics' Return on Assets (Quarter) stood at 0.02% in 2021, then tumbled by -98bps to 0.0% in 2022, then plummeted by -2628bps to 0.01% in 2023, then tumbled by -1824bps to 0.22% in 2024, then surged by 55bps to 0.1% in 2025.
  • Its Return on Assets stands at 0.1% for Q3 2025, versus 0.25% for Q2 2025 and 0.23% for Q1 2025.